ENTRY       K09617                      KO
NAME        KLK5
DEFINITION  kallikrein 5 [EC:3.4.21.-]
BRITE       Enzymes [BR:ko01000]
             3. Hydrolases
              3.4  Acting on peptide bonds (peptidases)
               3.4.21  Serine endopeptidases
                3.4.21.-  
                 K09617  KLK5; kallikrein 5
            Peptidases [BR:ko01002]
             Serine Peptidases
              Family S1: chymotrypsin family
               K09617  KLK5; kallikrein 5
GENES       HSA: 25818(KLK5)
            PTR: 748162(KLK5)
            PPS: 100981050
            GGO: 101147481(KLK5)
            PON: 100434635(KLK5)
            MCC: 719467(KLK5)
            MCF: 102141287(KLK5)
            MMU: 68668(Klk5)
            CGE: 100756768(Klk5)
            HGL: 101717747(Klk5)
            TUP: 102503045(KLK5)
            CFA: 484353(KLK5)
            AML: 100478955
            FCA: 101090566(KLK5)
            PTG: 102963880(KLK5)
            BTA: 617418(KLK5)
            BOM: 102286390(KLK5)
            PHD: 102315197(KLK5)
            CHX: 102178008(KLK5)
            CFR: 102521270(KLK5)
            BACU: 102998436(KLK5)
            LVE: 103070309(KLK5)
            ECB: 100067348(KLK5)
            MYB: 102249183(KLK5)
            MYD: 102765026(KLK5)
            PALE: 102898231(KLK5)
            MDO: 100012632(KLK5)
            SHR: 100933909(KLK5)
REFERENCE   PMID:23086576
  AUTHORS   Papachristopoulou G, Talieri M, Scorilas A
  TITLE     Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate.
  JOURNAL   Tumour Biol 34:369-78 (2013)
///
